$700k cash in the kitty and 0.7 quarters on funding available.
The directors are confident in the Company's ability to raise further capital to fund operations going forward via a number of alternatives with the support of its strong shareholder base.
Remaining Didievi assays pending - post release SP pump into placement or placement & underwritten entitlement offer?
A lot of things wrong with this bucket at the moment:
- Extremely slow moving - Lack of promotion - No cash and cum raise
But in control of what potentially could become a great project. Directors need to get this thing moving or bring someone on board who can.
A1G Price at posting:
9.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)